news
A study has demonstrated that the LY6E protein inhibits SARS-CoV-2…
29 July 2020 | By Victoria Rees (Drug Target Review)
A study has demonstrated that the LY6E protein inhibits SARS-CoV-2 infection in human cell cultures, so a drug mimicking it could be a therapy for COVID-19.